Form ABS-15G GE COMMERCIAL MORTGAGE

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM ABS-15G

 ASSET-BACKED SECURITIZER
Report Pursuant to Section 15G of the Securities Exchange Act of 1934

Check the appropriate box to indicate the filing obligation to which this form is intended to satisfy:

____ Rule 15Ga-1 under the Exchange Act (17 CFR 240.15Ga-1) for the reporting period _____________ to _____________

April 9, 2025
Date of Report

GE Commercial Mortgage Corporation
(Exact name of securitizer as specified in its charter)

 

025-01035	0001215087
(Commission File Number of securitizer)	(Central Index Key Number of securitizer)

 

Elena Haliulin, (203) 229-8655
(Name and telephone number, including area code, of the person to contact in connection with this filing)

 

Indicate by check mark whether the securitizer has no activity to report for the initial period pursuant to Rule 15Ga-1(c)(1) [_]

Indicate by check mark whether the securitizer has no activity to report for the quarterly period pursuant to Rule 15Ga-1(c)(2)(i) [_]

Indicate by check mark whether the securitizer has no activity to report for the annual period pursuant to Rule 15Ga-1(c)(2)(ii) [_]

  

 

Item 1.03 Notice of Termination of Duty to File Reports under Rule 15Ga-1

The date of the last payment on the last asset-backed security outstanding that was issued by or issued by an affiliate of the securitizer was January 10, 2023.

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the reporting entity has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Date: April 9, 2025	GE COMMERCIAL MORTGAGE CORPORATION
	(Securitizer)
	By: GE Capital US Holdings, Inc., as successor-in-interest to GE Commercial Mortgage Corporation for the purpose of winding up its affairs
	By:	/s/ Elena Haliulin
		Name:	Elena Haliulin
		Title:	Vice President

 

 

 

 

 

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• CapitalXtend Launches New Brand Identity and Enhanced Digital Experience
• From Meme Coin to Trading Infrastructure: Best Crypto Presale Buyers Back AlphaPepe’s Push Beyond the Usual PEPE Copycat Model
• RiboX Therapeutics Announces FDA IND Clearance for RXIM002, the first Circular RNA-Based in vivo CAR Therapy for Autoimmune Cytopenias